| Breakdown | TTM | Mar 2025 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.77B | 18.49B | 17.62B | 15.47B | 8.79B | 8.20B |
| Gross Profit | 2.36B | 2.30B | 2.21B | 1.73B | 1.39B | 1.46B |
| EBITDA | 1.42B | 1.26B | 762.00M | 732.00M | 655.00M | 819.00M |
| Net Income | 316.00M | 149.00M | -309.00M | -576.00M | 247.00M | 467.00M |
Balance Sheet | ||||||
| Total Assets | 34.45B | 34.59B | 33.25B | 30.52B | 28.57B | 13.01B |
| Cash, Cash Equivalents and Short-Term Investments | 1.72B | 2.27B | 976.00M | 810.00M | 1.25B | 2.17B |
| Total Debt | 4.64B | 3.52B | 4.66B | 3.69B | 2.93B | 1.64B |
| Total Liabilities | 24.68B | 24.01B | 24.48B | 21.49B | 19.45B | 9.68B |
| Stockholders Equity | 9.67B | 10.46B | 8.67B | 8.91B | 9.04B | 3.27B |
Cash Flow | ||||||
| Free Cash Flow | -111.00M | 490.00M | -567.00M | -1.00B | -720.00M | 202.00M |
| Operating Cash Flow | 382.00M | 972.00M | -82.00M | -577.00M | -455.00M | 476.00M |
| Investing Cash Flow | -521.00M | 123.00M | -431.00M | -443.00M | -1.94B | -368.00M |
| Financing Cash Flow | 80.00M | 244.00M | 696.00M | 558.00M | 1.46B | -1.36B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | €136.33B | 17.32 | 35.36% | 0.97% | 14.19% | 161.87% | |
73 Outperform | €74.37B | 13.71 | 16.66% | 3.96% | 3.21% | 4.24% | |
69 Neutral | €13.60B | 11.12 | 14.39% | 3.87% | 7.71% | -2.82% | |
67 Neutral | €12.12B | 11.61 | 3.25% | ― | 4.58% | ― | |
66 Neutral | €138.10B | 30.00 | 23.44% | 1.53% | 7.05% | 54.98% | |
64 Neutral | €19.56B | 14.13 | 8.45% | 4.51% | 0.88% | -2.06% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |